ARTICLE | Clinical News
Bisphosphonates cancer data
September 19, 2011 7:00 AM UTC
Marketed bisphosphonates include Fosamax alendronate from Merck & Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.); Boniva ibandronate from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) and ...